Skip to main content
. 2022 Oct 25;9:988820. doi: 10.3389/fcvm.2022.988820

TABLE 6.

Clinical outcomes stratified by treatment strategy.

Deferred N = 179 Performed N = 75 Against FFR N = 23 P-value
VOCE 10 (5.6%) 7 (9.3%) 3 (13.0%) 0.305
Death 5 (2.8%) 3 (4.0%) 0 (0.0%) 0.600
Non-fatal MI 1 (0.6%) 0 (0.0%) 0 (0.0%) 0.760
TVR 6 (3.4%) 4 (5.3%) 3 (13.0%) 0.112

VOCE, vessel-oriented composite endpoint; MI, myocardial infarction; TVR, target vessel revascularization.